Chitosan nanoparticles: a survey of preparation methods

References

• Agnihotri SA, Aminabhavi TM. (2007). Chitosan nanoparticles for prolonged delivery of timolol maleate. Drug Dev Ind Pharm, 33, 1254–1262.
   PubMed Web of Science ®Google Scholar
• Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. (2004). Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release, 100, 5–28.
   PubMed Web of Science ®Google Scholar
• Agrawal P, Strijkers GJ, Nicolay K. (2010). Chitosan-based systems for molecular imaging. Adv Drug Deliv Rev, 62, 42–58.
   PubMed Web of Science ®Google Scholar
• Al-Qadi S, Grenha A, Remuñán-López C. (2012). Chitosan and its derivatives as nanocarriers for siRNA delivery. J Drug Deliv Sci Technol (accepted).
   Google Scholar
• Al-Qadi S, Grenha A, Carrión-Recio D, Seijo B, Remuñán-López C. (2011). Microencapsulated chitosan nanoparticles for pulmonary protein delivery: in vivo evaluation of insulin-loaded formulations. J Control Release. doi:10.1016/j.jconrel.2011.08.008.
   PubMed Web of Science ®Google Scholar
• Alonso MJ. (1996). Nanoparticulate drug carrier technology. In: Cohen S, Bernstein H, eds. Microparticulate Systems for the Delivery of Proteins and Vaccines. New York: Marcel Dekker, 203–242.
   Google Scholar
• Alonso MJ. (2004). Nanomedicines for overcoming biological barriers. Biomed Pharmacother, 58, 168–172.
   PubMed Web of Science ®Google Scholar
• Alonso-Sande M, Cuña M, Remuñán-López C, Teijeiro-Osorio D, Alonso-Lebrero JL, Alonso MJ. (2006). Formation of new glucomannan-chitosan nanoparticles and study of their ability to associate and deliver proteins. Macromolecules, 39, 4152–4158.
   Web of Science ®Google Scholar
• Andrade F, Antunes F, Nascimento AV, da Silva SB, das Neves J, Ferreira D, Sarmento B. (2011). Chitosan formulations as carriers for therapeutic proteins. Curr Drug Discov Technol, 8, 157–172.
   PubMedGoogle Scholar
• Anto SM, Kannan C, Kumar KS, Kumar SV, Suganeshwari M. (2011). Formulation of 5-fluorouracil loaded chitosan nanoparticles by emulsion droplet coalescence method for cancer therapy. Int J Pharm Biol Arch, 2, 926–931.
   Google Scholar
• Atyabi F, Talaie F, Dinarvand R. (2009). Thiolated chitosan nanoparticles as an oral delivery system for Amikacin: in vitro and ex vivo evaluations. J Nanosci Nanotechnol, 9, 4593–4603.
   PubMed Web of Science ®Google Scholar
• Avadi MR, Sadeghi AM, Mohammadpour N, Abedin S, Atyabi F, Dinarvand R, Rafiee-Tehrani M. (2010). Preparation and characterization of insulin nanoparticles using chitosan and Arabic gum with ionic gelation method. Nanomedicine, 6, 58–63.
   PubMed Web of Science ®Google Scholar
• Azizi E, Namazi A, Haririan I, Fouladdel S, Khoshayand MR, Shotorbani PY, Nomani A, Gazori T. (2010). Release profile and stability evaluation of optimized chitosan/alginate nanoparticles as EGFR antisense vector. Int J Nanomedicine, 5, 455–461.
   PubMed Web of Science ®Google Scholar
• Baldrick P. (2010). The safety of chitosan as a pharmaceutical excipient. Regul Toxicol Pharmacol, 56, 290–299.
   PubMed Web of Science ®Google Scholar
• Banerjee T, Mitra S, Kumar Singh A, Kumar Sharma R, Maitra A. (2002). Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles. Int J Pharm, 243, 93–105.
   PubMed Web of Science ®Google Scholar
• Bayat A, Larijani B, Ahmadian S, Junginger HE, Rafiee-Tehrani M. (2008). Preparation and characterization of insulin nanoparticles using chitosan and its quaternized derivatives. Nanomedicine, 4, 115–120.
   PubMed Web of Science ®Google Scholar
• Berthold A, Cremer K, Kreuter J. (1996). Preparation and characterisation of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs. J Control Rel, 39, 17–25.
   Web of Science ®Google Scholar
• Bhattarai N, Gunn J, Zhang M. (2010). Chitosan-based hydrogels for controlled, localized drug delivery. Adv Drug Deliv Rev, 62, 83–99.
   PubMed Web of Science ®Google Scholar
• Bisht S, Maitra A. (2009). Dextran-doxorubicin/chitosan nanoparticles for solid tumor therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol, 1, 415–425.
   PubMed Web of Science ®Google Scholar
• Blau S, Jubeh TT, Haupt SM, Rubinstein A. (2000). Drug targeting by surface cationization. Crit Rev Ther Drug Carrier Syst, 17, 425–465.
   PubMed Web of Science ®Google Scholar
• Bodmeier R, Chen HG, Paeratakul O. (1989). A novel approach to the oral delivery of micro- or nanoparticles. Pharm Res, 6, 413–417.
   PubMed Web of Science ®Google Scholar
• Bonferoni MC, Sandri G, Rossi S, Ferrari F, Caramella C. (2009). Chitosan and its salts for mucosal and transmucosal delivery. Expert Opin Drug Deliv, 6, 923–939.
   PubMed Web of Science ®Google Scholar
• Borges O, Borchard G, Verhoef JC, de Sousa A, Junginger HE. (2005). Preparation of coated nanoparticles for a new mucosal vaccine delivery system. Int J Pharm, 299, 155–166.
   PubMed Web of Science ®Google Scholar
• Bowman K, Leong KW. (2006). Chitosan nanoparticles for oral drug and gene delivery. Int J Nanomedicine, 1, 117–128.
   PubMed Web of Science ®Google Scholar
• Calvo P, Remuñan-Lopez C, Vila-Jato JL, Alonso MJ. (1997). Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Polym Sci, 63, 125–132.
   Web of Science ®Google Scholar
• Canelas DA, Herlihy KP, DeSimone JM. (2009). Top-down particle fabrication: control of size and shape for diagnostic imaging and drug delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol, 1, 391–404.
   PubMed Web of Science ®Google Scholar
• Carvalho EL, Grenha A, Remuñán-López C, Alonso MJ, Seijo B. (2009). Mucosal delivery of liposome-chitosan nanoparticle complexes. Meth Enzymol, 465, 289–312.
   PubMed Web of Science ®Google Scholar
• Chan HK, Kwok PC. (2011). Production methods for nanodrug particles using the bottom-up approach. Adv Drug Deliv Rev, 63, 406–416.
   PubMed Web of Science ®Google Scholar
• Chaudhury A, Das S. (2011). Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents. AAPS PharmSciTech, 12, 10–20.
   PubMed Web of Science ®Google Scholar
• Chiellini F, Piras AM, Errico C, Chiellini E. (2008). Micro/nanostructured polymeric systems for biomedical and pharmaceutical applications. Nanomedicine (Lond), 3, 367–393.
   PubMed Web of Science ®Google Scholar
• Csaba N, Garcia-Fuentes M, Alonso MJ. (2006). The performance of nanocarriers for transmucosal drug delivery. Expert Opin Drug Deliv, 3, 463–478.
   PubMedGoogle Scholar
• Cuña M, Alonso-Sandel M, Remuñán-López C, Pivel JP, Alonso-Lebrero JL, Alonso MJ. (2006). Development of phosphorylated glucomannan-coated chitosan nanoparticles as nanocarriers for protein delivery. J Nanosci Nanotechnol, 6, 2887–2895.
   PubMed Web of Science ®Google Scholar
• das Neves J, Bahia MF, Amiji MM, Sarmento B. (2011). Mucoadhesive nanomedicines: characterization and modulation of mucoadhesion at the nanoscale. Expert Opin Drug Deliv, 8, 1085–1104.
   PubMed Web of Science ®Google Scholar
• De Campos AM, Sánchez A, Alonso MJ. (2001). Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. Int J Pharm, 224, 159–168.
   PubMed Web of Science ®Google Scholar
• de la Fuente M, Csaba N, Garcia-Fuentes M, Alonso MJ. (2008a). Nanoparticles as protein and gene carriers to mucosal surfaces. Nanomedicine, 3, 845–857.
   PubMed Web of Science ®Google Scholar
• de la Fuente M, Seijo B, Alonso MJ. (2008b). Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy. Invest Ophtalmol Vis Sci, 49, 2016–2024.
   PubMed Web of Science ®Google Scholar
• Desai MP, Labhasetwar V, Amidon GL, Levy RJ. (1996). Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res, 13, 1838–1845.
   PubMed Web of Science ®Google Scholar
• Du J, Sun R, Zhang S, Govender T, Zhang LF, Xiong CD, Peng YX. (2004). Novel polyelectrolyte carboxymethyl konjac glucomannan-chitosan nanoparticles for drug delivery. Macromol Rapid Commun, 25, 954–958.
   Web of Science ®Google Scholar
• Duceppe N, Tabrizian M. (2010). Advances in using chitosan-based nanoparticles for in vitro and in vivo drug and gene delivery. Expert Opin Drug Deliv, 7, 1191–1207.
   PubMed Web of Science ®Google Scholar
• El-Shabouri MH. (2002). Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A. Int J Pharm, 249, 101–108.
   PubMed Web of Science ®Google Scholar
• Elsayed A, Al-Remawi M, Qinna N, Farouk A, Al-Sou’od KA, Badwan AA. (2011). Chitosan-sodium lauryl sulfate nanoparticles as a carrier system for the in vivo delivery of oral insulin. AAPS PharmSciTech, 12, 958–964.
   PubMed Web of Science ®Google Scholar
• Erbacher P, Zou S, Bettinger T, Steffan AM, Remy JS. (1998). Chitosan-based vector/DNA complexes for gene delivery: biophysical characteristics and transfection ability. Pharm Res, 15, 1332–1339.
   PubMed Web of Science ®Google Scholar
• Fan W, Yan W, Xu Z, Ni H. (2012). Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique. Colloids Surf B Biointerfaces, 90, 21–27.
   PubMed Web of Science ®Google Scholar
• FDA. (2005). Guidance for industry – Nonclinical studies for the safety evaluation of pharmaceutical excipients. [Online] Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm079250.pdf. Accessed 8 December 2011.
   Google Scholar
• Goycoolea FM, Lollo G, Remuñán-López C, Quaglia F, Alonso MJ. (2009). Chitosan-alginate blended nanoparticles as carriers for the transmucosal delivery of macromolecules. Biomacromolecules, 10, 1736–1743.
   PubMed Web of Science ®Google Scholar
• Grabnar PA, Kristl J. (2010). Physicochemical characterization of protein-loaded pectin-chitosan nanoparticles prepared by polyelectrolyte complexation. Pharmazie, 65, 851–852.
   PubMed Web of Science ®Google Scholar
• Grenha A, Al-Qadi S, Seijo B, Remuñán-Lopez C. (2010a). The potential of chitosan for pulmonary drug delivery. J Drug Deliv Sci Technol, 20, 33–43.
   Web of Science ®Google Scholar
• Grenha A, Gomes ME, Rodrigues M, Santo VE, Mano JF, Neves NM, Reis RL. (2010b). Development of new chitosan/carrageenan nanoparticles for drug delivery applications. J Biomed Mater Res A, 92, 1265–1272.
   PubMed Web of Science ®Google Scholar
• Grenha A, Seijo B, Remuñán-López C. (2005). Microencapsulated chitosan nanoparticles for lung protein delivery. Eur J Pharm Sci, 25, 427–437.
   PubMed Web of Science ®Google Scholar
• Hirano S, Seino H, Akiyama Y, Nonaka I. (1988). Biocompatibility of chitosan by oral and intravenous administrations. Polym Mater Sci Eng, 59, 897–901.
   Google Scholar
• Hu Y, Jiang X, Ding Y, Ge H, Yuan Y, Yang C. (2002). Synthesis and characterization of chitosan-poly(acrylic acid) nanoparticles. Biomaterials, 23, 3193–3201.
   PubMed Web of Science ®Google Scholar
• Huang M, Khor E, Lim LY. (2004). Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation. Pharm Res, 21, 344–353.
   PubMed Web of Science ®Google Scholar
• Ichikawa H, Tokumitsu H, Miyamoto M, Fukumori Y. (2006). Nanoparticles for neutron capture therapy of cancer. In: Kumar C, ed. Nanomaterials for Cancer Therapy. Weinheim: Wiley-VCH, 87–121.
   Google Scholar
• Janes KA, Calvo P, Alonso MJ. (2001). Polysaccharide colloidal particles as delivery systems for macromolecules. Adv Drug Deliv Rev, 47, 83–97.
   PubMed Web of Science ®Google Scholar
• Jani P, Halbert GW, Langridge J, Florence AT. (1990). Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J Pharm Pharmacol, 42, 821–826.
   PubMed Web of Science ®Google Scholar
• Kaihara S, Suzuki Y, Fujimoto K. (2011). In situ synthesis of polysaccharide nanoparticles via polyion complex of carboxymethyl cellulose and chitosan. Colloids Surf B Biointerfaces, 85, 343–348.
   PubMed Web of Science ®Google Scholar
• Kean T, Thanou M. (2010). Biodegradation, biodistribution and toxicity of chitosan. Adv Drug Deliv Rev, 62, 3–11.
   PubMed Web of Science ®Google Scholar
• Keawchaoon L, Yoksan R. (2011). Preparation, characterization and in vitro release study of carvacrol-loaded chitosan nanoparticles. Colloids Surf B Biointerfaces, 84, 163–171.
   PubMed Web of Science ®Google Scholar
• Kissel T, Maretscheck S, Packhäuser C, Schnieders J, Seidel N. (2006). Microencapsulation techniques for parenteral depot systems and their application in the pharmaceutical industry. In: Benita S, ed. Microencapsulation: Methods and Industrial Applications. New York: Taylor & Francis, 99–122.
   Google Scholar
• Lehr CM, Bouwstra JA, Schacht EH, Junginger HE. (1992). In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int J Pharm, 78, 43–48.
   Web of Science ®Google Scholar
• Lin YH, Mi FL, Chen CT, Chang WC, Peng SF, Liang HF, Sung HW. (2007). Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery. Biomacromolecules, 8, 146–152.
   PubMed Web of Science ®Google Scholar
• Lin YH, Sonaje K, Lin KM, Juang JH, Mi FL, Yang HW, Sung HW. (2008). Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs. J Control Release, 132, 141–149.
   PubMed Web of Science ®Google Scholar
• Liu H, Chen B, Mao Z, Gao C. (2007a). Chitosan nanoparticles for loading of toothpaste actives and adhesion on tooth analogs. J Appl Polym Sci, 106, 4248–4256.
   Web of Science ®Google Scholar
• Liu Z, Jiao Y, Liu F, Zhang Z. (2007b). Heparin/chitosan nanoparticle carriers prepared by polyelectrolyte complexation. J Biomed Mater Res A, 83, 806–812.
   PubMed Web of Science ®Google Scholar
• Luppi B, Bigucci F, Cerchiara T, Zecchi V. (2010). Chitosan-based hydrogels for nasal drug delivery: from inserts to nanoparticles. Expert Opin Drug Deliv, 7, 811–828.
   PubMed Web of Science ®Google Scholar
• Ma Z, Yeoh HH, Lim LY. (2002). Formulation pH modulates the interaction of insulin with chitosan nanoparticles. J Pharm Sci, 91, 1396–1404.
   PubMed Web of Science ®Google Scholar
• Malam Y, Lim EJ, Seifalian AM. (2011). Current trends in the application of nanoparticles in drug delivery. Curr Med Chem, 18, 1067–1078.
   PubMed Web of Science ®Google Scholar
• Manchanda R, Nimesh R. (2010). Controlled size chitosan nanoparticles as an efficient, biocompatible oligonucleotides delivery system. J Appl Polym Sci, 118, 2071–2077.
   Web of Science ®Google Scholar
• Mao HQ, Roy K, Troung-Le VL, Janes KA, Lin KY, Wang Y, August JT, Leong KW. (2001). Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release, 70, 399–421.
   PubMed Web of Science ®Google Scholar
• Maurya SK, Pathak K, Bali V. (2010). Therapeutic potential of mucoadhesive drug delivery systems–an updated patent review. Recent Pat Drug Deliv Formul, 4, 256–265.
   PubMedGoogle Scholar
• Mitra S, Gaur U, Ghosh PC, Maitra AN. (2001). Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier. J Control Release, 74, 317–323.
   PubMed Web of Science ®Google Scholar
• Nagpal K, Singh SK, Mishra DN. (2010). Chitosan nanoparticles: a promising system in novel drug delivery. Chem Pharm Bull, 58, 1423–1430.
   PubMed Web of Science ®Google Scholar
• Niwa T, Takeuchi H, Hino T, Kunou N, Kawashima Y. (1993). Preparation of biodegradable nanospheres of water soluble and insoluble drugs with D,L-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior. J Control Rel, 2, 89–98.
   Google Scholar
• Ohya Y, Shiratani M, Kobayashi H, Ouchi T. (1994). Release behaviour of 5-fluorouracil from chitosan-gel nanospheres immobilizing 5-fluorouracil coated with polysaccharides and their cell specific cytotoxicity. Pure Appl Chem, A31, 629–642.
   Web of Science ®Google Scholar
• Oyarzun-Ampuero FA, Brea J, Loza MI, Torres D, Alonso MJ. (2009). Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma. Int J Pharm, 381, 122–129.
   PubMed Web of Science ®Google Scholar
• Park JH, Saravanakumar G, Kim K, Kwon IC. (2010). Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv Drug Deliv Rev, 62, 28–41.
   PubMed Web of Science ®Google Scholar
• Pileni MP. (2006). Reverse micelles used as templates: a new understanding in nanocrystal growth. J Experim Nanosci, 1, 13–27.
   Web of Science ®Google Scholar
• Poncelet D. (2005). Microencapsulation: fundamentals, methods and applications. In: Blitz JP, Gun’ko VM, eds. Surface Chemistry in Biomedical and Environmental Science. Dordrecht: Springer, 23–34.
   Google Scholar
• Posadas I, Guerra FJ, Ceña V. (2010). Nonviral vectors for the delivery of small interfering RNAs to the CNS. Nanomedicine (Lond), 5, 1219–1236.
   PubMed Web of Science ®Google Scholar
• Prabaharan M, Mano JF. (2005). Chitosan-based particles as controlled drug delivery systems. Drug Deliv, 12, 41–57.
   PubMed Web of Science ®Google Scholar
• Rejinold N, Muthunarayanan M, Muthuchelian K, Chennazhi K, Nair S, Jayakumar R. (2011). Saponin-loaded chitosan nanoparticles and their cytotoxicity to cancer cell lines in vitro. Carb Polym, 84, 407–416.
   Web of Science ®Google Scholar
• Sajeesh S, Sharma CP. (2006a). Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery. Int J Pharm, 325, 147–154.
   PubMed Web of Science ®Google Scholar
• Sajeesh S, Sharma CP. (2006b). Novel pH responsive polymethacrylic acid-chitosan-polyethylene glycol nanoparticles for oral peptide delivery. J Biomed Mater Res Part B Appl Biomater, 76, 298–305.
   PubMed Web of Science ®Google Scholar
• Sarmento B, Martins S, Ribeiro A, Veiga F, Neufeld R, Ferreira D. (2006a). Development and comparison of different nanoparticulate polyelectrolyte complexes as insulin carriers. Int J Peptide Res Ther, 12, 131–138.
   Web of Science ®Google Scholar
• Sarmento B, Ribeiro A, Veiga F, Ferreira D. (2006b). Development and characterization of new insulin containing polysaccharide nanoparticles. Colloids Surf B Biointerfaces, 53, 193–202.
   PubMed Web of Science ®Google Scholar
• Sarmento Ribeiro, A, Veiga F, Ferreira D, Neufeld R. (2007). Oral bioavailability of insulin contained in polysaccharide nanoparticles. Biomacromolecules, 8, 3054–3060.
   PubMed Web of Science ®Google Scholar
• Schipper NG, Vårum KM, Artursson P. (1996). Chitosans as absorption enhancers for poorly absorbable drugs. 1: Influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (Caco-2) cells. Pharm Res, 13, 1686–1692.
   PubMed Web of Science ®Google Scholar
• Schipper NG, Vârum KM, Stenberg P, Ocklind G, Lennernäs H, Artursson P. (1999). Chitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancement. Eur J Pharm Sci, 8, 335–343.
   PubMed Web of Science ®Google Scholar
• Silva GA, Coutinho OP, Ducheyne P, Shapiro IM, Reis RL. (2007). Starch-based microparticles as vehicles for the delivery of active platelet-derived growth factor. Tissue Eng, 13, 1259–1268.
   PubMedGoogle Scholar
• Songjiang Z, Lixiang W. (2009). Amyloid-beta associated with chitosan nano-carrier has favorable immunogenicity and permeates the BBB. AAPS PharmSciTech, 10, 900–905.
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Yamamoto H, Kawashima Y. (2001). Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv Drug Deliv Rev, 47, 39–54.
   PubMed Web of Science ®Google Scholar
• Tan ML, Choong PF, Dass CR. (2009). Cancer, chitosan nanoparticles and catalytic nucleic acids. J Pharm Pharmacol, 61, 3–12.
   PubMed Web of Science ®Google Scholar
• Tang ZX, Qian JQ, Shi LE. (2007). Preparation of chitosan nanoparticles as carrier for immobilized enzyme. Appl Biochem Biotechnol, 136, 77–96.
   PubMed Web of Science ®Google Scholar
• Teijeiro-Osorio D, Remuñán-López C, Alonso MJ. (2009). New generation of hybrid poly/oligosaccharide nanoparticles as carriers for the nasal delivery of macromolecules. Biomacromolecules, 10, 243–249.
   PubMed Web of Science ®Google Scholar
• Terbojevich M, Muzzarelli RAA. (2009). Chitosan. In: Phillips GO, Williams P, eds. Handbook of Hydrocolloids. Cambridge: Woodhead Publishing Ltd., 367–378.
   Google Scholar
• Tian XX, Groves MJ. (1999). Formulation and biological activity of antineoplastic proteoglycans derived from Mycobacterium vaccae in chitosan nanoparticles. J Pharm Pharmacol, 51, 151–157.
   PubMed Web of Science ®Google Scholar
• Tiera MJ, Shi Q, Winnik FM, Fernandes JC. (2011). Polycation-based gene therapy: current knowledge and new perspectives. Curr Gene Ther, 11, 288–306.
   PubMed Web of Science ®Google Scholar
• Tiyaboonchai W. (2003). Chitosan nanoparticles: a promising system for drug delivery. Naresuan Univ J, 11, 51–66.
   Web of Science ®Google Scholar
• Tokumitsu H, Ichikawa H, Fukumori Y, Block LH. (1999a). Preparation of gadopentetic acid-loaded chitosan microparticles for gadolinium neutron-capture therapy of cancer by a novel emulsion-droplet coalescence technique. Chem Pharm Bull, 47, 838–842.
   PubMed Web of Science ®Google Scholar
• Tokumitsu H, Ichikawa H, Fukumori Y. (1999b). Chitosan-gadopentetic acid complex nanoparticles for gadolinium neutron-capture therapy of cancer: preparation by novel emulsion-droplet coalescence technique and characterization. Pharm Res, 16, 1830–1835.
   PubMed Web of Science ®Google Scholar
• Wang JJ, Zeng ZW, Xiao RZ, Xie T, Zhou GL, Zhan XR, Wang SL. (2011a). Recent advances of chitosan nanoparticles as drug carriers. Int J Nanomedicine, 6, 765–774.
   PubMed Web of Science ®Google Scholar
• Wang J, Byrne JD, Napier ME, DeSimone JM. (2011b). More effective nanomedicines through particle design. Small, 7, 1919–1931.
   PubMed Web of Science ®Google Scholar
• Wang X, Chi N, Tang X. (2008). Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting. Eur J Pharm Biopharm, 70, 735–740.
   PubMed Web of Science ®Google Scholar
• Xu J, Dai W, Wang Z, Chen B, Li Z, Fan X. (2011). Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen a protects mice against nasopharyngeal colonization by Streptococcus pneumoniae. Clin Vaccine Immunol, 18, 75–81.
   PubMed Web of Science ®Google Scholar
• Xu Y, Du Y. (2003). Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int J Pharm, 250, 215–226.
   PubMed Web of Science ®Google Scholar
• Yang SJ, Lin FH, Tsai HM, Lin CF, Chin HC, Wong JM, Shieh MJ. (2011). Alginate-folic acid-modified chitosan nanoparticles for photodynamic detection of intestinal neoplasms. Biomaterials, 32, 2174–2182.
   PubMed Web of Science ®Google Scholar
• Yeh MK, Cheng KM, Hu CS, Huang YC, Young JJ. (2011). Novel protein-loaded chondroitin sulfate-chitosan nanoparticles: preparation and characterization. Acta Biomater, 7, 3804–3812.
   PubMed Web of Science ®Google Scholar
• Zhang H, Oh M, Allen C, Kumacheva E. (2004). Monodisperse chitosan nanoparticles for mucosal drug delivery. Biomacromolecules, 5, 2461–2468.
   PubMed Web of Science ®Google Scholar
• Zheng C, Yan W, Li-Jun Z, Zhong-Qiu L. (2010). Nanocarriers: a general strategy for enhancement of oral bioavailability of poorly absorbed or pre-systemically metabolized drugs. Curr Drug Metab, 11, 197–207.
   PubMed Web of Science ®Google Scholar